Vanna Reisman
Obstetrics & Gynecology · Syracuse, NYNPI 1801878640
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 42.1% of the total. Reporting peaked in 2022 at $768 and has fallen 64.4% since, to $273 in 2025.
Across 118 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Exeltis, USA Inc.$263
- Pfizer$230
- Mayne Pharma Commercial LLC$216
- Astellas Pharma US Inc$196
- Therapeuticsmd, Inc.$162
- plus $358 from 10 others
What the payments were for
- Food & beverage$2,43499%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $1,037 |
| Exeltis, USA Inc. | 16 | $263 |
| Pfizer | 12 | $230 |
| Mayne Pharma Commercial LLC | 9 | $216 |
| Astellas Pharma US Inc | 8 | $196 |
| Therapeuticsmd, Inc. | 8 | $162 |
| Agile Therapeutics, Inc. | 5 | $84 |
| Avion Pharmaceuticals | 3 | $76 |
| Millicent US Inc | 2 | $51 |
| Axonics, Inc. | 1 | $28 |
| Coopersurgical, Inc. | 1 | $28 |
| Mylan Pharmaceuticals Inc. | 1 | $24 |
| Merck | 1 | $23 |
| Exact Sciences | 1 | $15 |
| Virtus Pharmaceuticals LLC | 1 | $14 |
| Scynexis, Inc. | 1 | $14 |
How this compares
$2,461 in reported general payments places this provider in the 85th percentile of 2,673 obstetrics & gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 23 | $1,896 |
| Estradiol | 33 | $1,126 |
| Raloxifene Hcl | 27 | $910 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Syracuse
- Renee MestadSyracuse$18K
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.